#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14902	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2113	701.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1703	1703	T	837	T,C	772,4	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14902	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2113	701.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1437	1437	C	869	C	819	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27480	23S	2890	2890	99.97	23S.l15.c30.ctg.1	3503	781.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2253	2253	C	916	C	853	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27480	23S	2890	2890	99.97	23S.l15.c30.ctg.1	3503	781.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2327	2327	A	859	A	809	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27480	23S	2890	2890	99.97	23S.l15.c30.ctg.1	3503	781.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2879	2879	C	859	C,T	808,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	66836	blaTEM	861	861	99.88	blaTEM.l15.c17.ctg.1	1576	4225.6	0	.	p	.	0	M180T	NONSYN	538	540	ATG	882	884	ACG	6319;6293;6291	A,G;C;G,T,A,C	5839,1;5901;5859,1,1,1	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2150	folP	855	855	100.0	folP.l15.c4.ctg.1	1527	140.0	1	SNP	p	R229S	1	.	.	685	687	AGC	976	978	AGC	238;239;239	A;G;C	224;221;221	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5650	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3361	167.6	1	SNP	p	S91F	1	.	.	271	273	TTC	609	611	TTC	148;150;149	T;T;C	138;140;138	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5650	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3361	167.6	1	SNP	p	D95G	1	.	.	283	285	GGC	621	623	GGC	150;150;151	G;G;C	135;138;140	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5650	gyrA	2751	2751	100.0	gyrA.l6.c4.ctg.1	3361	167.6	1	SNP	p	G95N	0	.	.	283	285	GGC	621	623	GGC	150;150;151	G;G;C	135;138;140	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	539	1616	mtrR	633	633	99.37	mtrR.l15.c30.ctg.1	1444	111.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	544	546	ACC	181;179;180	A;C;C	171;173;172	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	914	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1098	83.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5128	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2991	170.9	0	.	p	.	0	E91G	NONSYN	271	273	GAG	541	543	GGG	200;200;198	G;G,T;G	189;188,1;186	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5128	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2991	170.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1573	1575	GCA	180;184;186	G;C;A	168;168;169	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5128	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2991	170.9	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2056	2058	ATT	238;237;237	A;T;T	214;217;218	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5128	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2991	170.9	1	SNP	p	D86N	0	.	.	256	258	GAC	526	528	GAC	192;191;192	G;A;C	180;179;182	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5128	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2991	170.9	1	SNP	p	S87I	0	.	.	259	261	AGT	529	531	AGT	193;191;191	A;G;T	185;183;181	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5128	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2991	170.9	1	SNP	p	S87R	0	.	.	259	261	AGT	529	531	AGT	193;191;191	A;G;T	185;183;181	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5128	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2991	170.9	1	SNP	p	S87W	0	.	.	259	261	AGT	529	531	AGT	193;191;191	A;G;T	185;183;181	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5128	parC	2304	2304	99.7	parC.l6.c4.ctg.1	2991	170.9	1	SNP	p	S88P	0	.	.	262	264	TCC	532	534	TCC	194;196;198	T;C;C	186;187;189	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4688	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2697	173.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1507	1509	GGC	220;216;216	G;G;C	200;196;197	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	4252	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	170.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1292	1294	GCA	234;232;231	G;C;A	212;212;215	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4252	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	170.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1295	1297	ATC	230;232;234	A;T,A;C,A	213;214,1;213,1	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4252	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	170.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1307	1309	GTG	228;226;226	G;T;G,T	208;207;201,1	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4252	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	170.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1307	1309	GTG	228;226;226	G;T;G,T	208;207;201,1	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4252	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	170.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1811	1813	ACC	214;213;219	A;C;C	199;200;207	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4252	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	170.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1865	1867	GCG	222;221;219	G;C;G	192;158;172	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4252	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	170.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1865	1867	GCG	222;221;219	G;C;G	192;158;172	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4252	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	170.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1988	1990	GGC	161;158;159	G;G;C,T	143;141;141,1	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4252	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	170.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1997	1999	GGC	155;157;159	G,A;G,T;C	135,1;134,1;139	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4252	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2483	170.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2015	2017	CCG	124;126;122	C,G;C;G,C	105,4;102;102,1	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	5988	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3142	190.1	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1495	1497	ACG	199;196;198	A,T;C;G	186,1;182;180	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2312	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1914	120.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	375	377	GGC	152;151;153	G,A;G;C	138,1;138;138	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2312	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1914	120.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	557	557	C	159	C	147	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	T87A	NONSYN	259	261	ACT	583	585	GCT	238;240;240	G;C;T	224;226;227	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	T89S	NONSYN	265	267	ACC	589	591	AGC	243;243;247	A;G;C,A	227;234;231,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	K120D	NONSYN	358	360	AAG	682	684	GAC	228;224;223	G;A,C;C	210;206,1;206	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	A151V	NONSYN	451	453	GCA	775	777	GTA	262;265;261	G;T;A	247;249;242	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	K207E	NONSYN	619	621	AAA	943	945	GAA	281;280;278	G;A;A	267;269;267	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1081	1083	CAA	205;207;208	C;A;A	192;196;197	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	.	INDELS	760	761	AC	1085	1088	ATCA	203;198;194;195	A;T;C;A	195;189;189;189	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	.	MULTIPLE	764	765	AC	1093	1095	TTG	193;191;195	T;T;G	184;182;188	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1099	1101	GAT	191;193;195	G;A;T	180;183;185	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	A270V	NONSYN	808	810	GCG	1138	1140	GTG	198;201;200	G;T;G	190;191;190	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	L277V	NONSYN	829	831	TTA	1159	1161	GTA	188;188;189	G;T;A	177;176;178	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	S290T	NONSYN	868	870	TCT	1198	1200	ACT	223;222;220	A;C;T	204;207;207	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	H292D	NONSYN	874	876	CAT	1204	1206	GAT	223;223;220	G;A;T	211;210;210	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	Y296H	NONSYN	886	888	TAC	1216	1218	CAC	221;222;221	C;A;C	212;211;212	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	2822	porB1b	1041	1041	97.23	porB1b.l15.c4.ctg.1	1515	185.4	0	.	p	.	0	I333S	NONSYN	997	999	ATC	1327	1329	AGC	193;190;186	A;G;C	181;180;174	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11518	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4915	233.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2066	2068	AAT	237;236;236	A;A;T,A	223;221;220,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1286	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1154	111.1	1	SNP	p	V57M	1	.	.	169	171	ATG	595	597	ATG	238;235;234	A;T;G	227;224;222	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
